- Home
- MGYR vs COEP Comparison
MGYR vs COEP Comparison
Compare MGYR & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGYR | COEP |
|---|---|---|
| Founded | 1922 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 100.4M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGYR | COEP |
|---|---|---|
| Price | $18.25 | $11.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.7K | ★ 63.6K |
| Earning Date | 01-29-2026 | 03-27-2026 |
| Dividend Yield | ★ 2.17% | N/A |
| EPS Growth | ★ 31.86 | N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $36,540,000.00 | $500,996.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.71 | ★ N/A |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $13.52 | $6.26 |
| 52 Week High | $19.04 | $21.41 |
Technical Indicators
Market Signals| Indicator | MGYR | COEP |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 32.99 |
| Support Level | N/A | $10.49 |
| Resistance Level | N/A | $15.94 |
| Average True Range (ATR) | 0.00 | 1.21 |
| MACD | 0.00 | -0.22 |
| Stochastic Oscillator | 0.00 | 9.91 |
Price Performance
Historical ComparisonAbout MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.